A recent study has uncovered how a common gut bacterium, Bacteroides fragilis, harms the colon, contributing to conditions like colorectal cancer. For years, scientists knew that this bacterium could promote tumor growth by releasing a toxin that damages intestinal cells, but the exact process remained a mystery.
Researchers from Johns Hopkins University have now pinpointed that the toxin, known as BFT, attaches to a receptor called claudin-4 on colon cells. This binding is crucial for the toxin to inflict damage. Senior researcher Cynthia Sears expressed excitement about the findings, highlighting that this knowledge could lead to new detection and treatment options for diseases linked to this bacterium. Studies funded partially by the National Institutes of Health emphasize the importance of understanding bacterial toxins for better health outcomes.
Bacteroides fragilis is found in about 20% of healthy individuals. It’s responsible for triggering inflammation in the gut, which can lead to tumor formation. Sears’ previous research indicated that the toxin disrupts E-cadherin, a protein vital for maintaining the colon’s protective barrier, but it didn’t interact directly with it. Instead, another mechanism was put into play, leading to the discovery of claudin-4 through advanced gene-editing techniques.
Interestingly, the research team found that many had assumed the receptor would be a type of signaling protein. This revelation sets BFT apart from typical toxins, as it binds to a separate receptor before causing damage. Collaborations with structural biologists confirmed the connection between BFT and claudin-4, presenting strong evidence for their interaction.
The team even developed a decoy version of claudin-4 to protect mice from the toxin. This innovative approach suggests potential future treatments that could effectively block the toxin’s harmful effects on the colon. The researchers are now exploring various ways to enhance this strategy. Despite the progress, they note that more work is needed to fully understand the interaction between BFT and claudin-4.
This discovery is not only crucial for understanding colon health but may also reflect broader trends in healthcare research. As studies increasingly focus on the gut microbiome and its impact on various diseases, this finding emphasizes the need for innovative and targeted therapies. For additional insights into the importance of gut health, the National Institute of Health offers comprehensive resources.
Reference: “A pro-carcinogenic bacterial toxin binds claudin-4 to cleave E-cadherin,” *Nature*.
Source link
Bacteria,Cancer,Colon,Gut,Johns Hopkins Medicine,Microbiology
